Back to Results
First PageMeta Content
SEC filings / Business / Mergers and acquisitions / Proxy statement / Finance / Allergan / Valeant Pharmaceuticals / J. Michael Pearson


International Headquarters 2150 St. Elzéar Blvd. West Laval, Quebec H7L 4A8 Phone: [removed]Fax: [removed]
Add to Reading List

Document Date: 2014-09-24 09:45:38

Open Document

File Size: 164,17 KB

Share Result on Facebook

City

Laval / Dupont Drive Irvine / Irvine / /

Company

Valeant Pharmaceuticals / Valeant Pharmaceuticals International Inc. / Lead Independent Director Allergan Inc. / Allergan Inc. / Pershing Square Capital Management L.P. / Laurie W. Little Valeant Pharmaceuticals International Inc. / I. Pyott Michael R. Gallagher / E. Soto/Meghan Gavigan Sard Verbinnen & Co. / /

Country

United States / Canada / /

/

Event

Person Communication and Meetings / Conference Call / M&A / Reorganization / /

Facility

International Headquarters / /

/

IndustryTerm

pharmaceutical industry / pharmaceutical products / pharmaceutical / healthcare / /

Organization

CSA / U.S. Securities and Exchange Commission / /

Person

David Pyott / Michael Gallagher / J. Michael Pearson / Michael R. Gallagher / David E.I. Pyott Michael / /

/

Position

CEO / Governor / DIRECTOR Overall Same Store Organic Growth / Chairman and Chief Executive Officer / Director / Chairman & Chief Executive Officer / CEO AND LEAD INDEPENDENT DIRECTOR / Chairman of the Board and Chief Executive Officer Lead Independent Director / astute and well-respected businessman / Private / Chairman & CEO / /

ProvinceOrState

Quebec / California / /

Technology

pharmaceutical products / /

URL

www.valeant.com / http /

SocialTag